Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...

The chief executive of generic drugmaker Sandoz said a proposal by the CEOs of Novartis and Sanofi to introduce a Europe-wide ...

Singapore is negotiating concessions for pharmaceutical exports to the U.S. while ensuring it still has access to high-end AI ...

Revvity reported first-quarter results above Wall Street estimates and maintained its full-year profit forecast on Monday, ...

Welltower forecast annual funds from operations (FFO) above estimates on Monday, betting on strong demand for the healthcare real estate investment trust's assisted living and senior housing ...

Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 billion to add ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...

Their own mini-boom of recent years has been largely fueled by one firm, Ozempic maker Novo Nordisk A/S, whose diabetes and ...

European shares extended gains on Monday, with most sub-indexes rising, as investors remained optimistic about U.S.-China ...

EUROPEAN shares extended gains on Monday, with most sub-indexes rising, as investors remained optimistic about US-China trade tensions easing ahead of the week’s earnings and economic data. Read more ...

European stock markets closed higher Monday as the Stoxx Europe 600 rose 0.5%, Germany's DAX 40 increased 0.06%, the FTSE 100 edged up 0.02%, France's CAC 40 gained 0.5% and the Swiss Market Index ...